enuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.

Russell N., Burnett A., Hills R., Betteridge S., Dennis M., Jovanovic J., Dillon R., Grimwade D., NCRI AML Working Group .

DOI

10.1182/blood-2018-05-851824

Type

Journal article

Publication Date

2018-09-27T00:00:00+00:00

Volume

132

Pages

1452 - 1454

Total pages

2

Keywords

Adolescent, Adult, Aged, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Arsenic Trioxide, Female, Follow-Up Studies, Humans, Leukemia, Promyelocytic, Acute, Male, Middle Aged, Neoplasm Recurrence, Local, Survival Analysis, Tretinoin, Young Adult

Permalink More information Close